This article was originally published in The Rose Sheet
Executive SummaryTwo new innovation centers at firm's Atlas Point manufacturing site in New Castle, Del. "will only allow Croda to be more competitive in the marketplace and further support [its] standing as a world-class supplier of quality chemical specialties," according to Oct. 23 release. Atlas Point Commercial Center will house company's Skin Care Innovation Laboratory, while William C. Griffin Innovation Center will support R&D projects in industrial markets, Croda says. Firm has committed $20 mil. to renovating the site since picking it up in 2006 acquisition of functional ingredient manufacturer Uniqema. Further expenditures at facility are expected over next decade, firm says
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.